Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease
- 1 September 1999
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 117 (3), 527-535
- https://doi.org/10.1016/s0016-5085(99)70445-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- 6-mercaptopurine (6MP)+ prednisone therapy for newly diagnosed pediatric Crohn's disease (CD): a prospective, multicenter, placebo-controlled clinical trialGastroenterology, 1998
- 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.Gut, 1996
- An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's diseaseGastroenterology, 1995
- Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemiaThe Lancet, 1994
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990
- Azathioprine Metabolism: Pharmacokinetics of 6‐Mercaptopurine, 6‐Thiouric Acid and 6‐Thioguanine Nucleotides in Renal Transplant PatientsThe Journal of Clinical Pharmacology, 1990
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980
- DOUBLE-BLIND WITHDRAWAL TRIAL OF AZATHIOPRINE AS MAINTENANCE TREATMENT FOR CROHN'S DISEASEThe Lancet, 1978
- A controlled trial of azathioprine in Crohn's diseaseDigestive Diseases and Sciences, 1975
- CONTROLLED TRIAL OF AZATHIOPRINE IN CROHN'S DISEASEThe Lancet, 1971